BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10171532)

  • 1. Pap smear furor may derail Clinton changes.
    Scott L
    Mod Healthc; 1993 Oct; 23(40):17. PubMed ID: 10171532
    [No Abstract]   [Full Text] [Related]  

  • 2. Who needs another test?
    BeSaw L
    Tex Med; 1996 Sep; 92(9):26-9. PubMed ID: 8826771
    [No Abstract]   [Full Text] [Related]  

  • 3. Harvard HMO improves Pap smear screening.
    Herman R
    QA Rev; 1989 Oct; 1(3):2-3. PubMed ID: 10318359
    [No Abstract]   [Full Text] [Related]  

  • 4. HMOs should stress quality tests in light of pap smear controversy.
    Johnson DE
    Contract Healthc; 1988 Feb; ():27. PubMed ID: 10318142
    [No Abstract]   [Full Text] [Related]  

  • 5. Are you ready for a CLIA inspection?
    Spencer C; Gorove C
    Internist; 1993 Sep; 34(8):32-3. PubMed ID: 10171698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Companies build Pap smear safety nets.
    Scott L
    Mod Healthc; 1995 May; 25(19):70. PubMed ID: 10142267
    [No Abstract]   [Full Text] [Related]  

  • 7. Pap smear concerns.
    Moran T
    Tex Med; 1997 Nov; 93(11):44-6. PubMed ID: 9369088
    [No Abstract]   [Full Text] [Related]  

  • 8. Building outpatient volume through Pap smear testing.
    Hatfield JD
    MLO Med Lab Obs; 1989 Mar; 21(3):77-9. PubMed ID: 10318268
    [No Abstract]   [Full Text] [Related]  

  • 9. A new era for the Pap test.
    Holladay EB; Allen KA
    JAAPA; 2001 Dec; 14(12):53-6. PubMed ID: 11824091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liability issues with the Papanicolaou smear: the view of a hospital administrator at Newport Hospital, Newport, Rhode Island.
    Sampson AJ
    Arch Pathol Lab Med; 1997 Mar; 121(3):241-5. PubMed ID: 9111108
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality concerns uncovered at laboratories doing waived tests.
    Szabo J
    MLO Med Lab Obs; 2001 Oct; 33(10):32-4. PubMed ID: 11688089
    [No Abstract]   [Full Text] [Related]  

  • 12. Waived testing.
    Hansen K; Lavanty D
    Clin Lab Sci; 2002; 15(1):4-5. PubMed ID: 12778947
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic testing: should clinical laboratory regs cover DNA analyses?
    Margolis RE
    Healthspan; 1992 Oct; 9(9):18-9. PubMed ID: 10171296
    [No Abstract]   [Full Text] [Related]  

  • 14. Are class 1 and class 2 Pap smears objectively interpreted?
    Berube LW
    Md State Med J; 1973 Sep; 22(9):54-8. PubMed ID: 4774187
    [No Abstract]   [Full Text] [Related]  

  • 15. The four R's: reactive/repair, reporting, and regulations.
    Moriarty AT; Young NA
    Diagn Cytopathol; 2003 Jul; 29(1):1-3. PubMed ID: 12827705
    [No Abstract]   [Full Text] [Related]  

  • 16. A look at Pap test accuracy and the duty to inform from a risk management perspective.
    Meister S
    QRC Advis; 1997 Dec; 14(2):1, 5-8. PubMed ID: 10176015
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare, Medicaid and CLIA programs; regulations implementing the Clinical Laboratory Improvement Amendments of 1988--HCFA. Final rule; correction.
    Fed Regist; 1993 Sep; 58(177):48323. PubMed ID: 10171695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLIA's effect on POLs (physicians' office laboratories).
    Strauss S; Cembrowski GS; Adlis SA
    MLO Med Lab Obs; 1995 Jun; 27(6):34-8. PubMed ID: 10172324
    [No Abstract]   [Full Text] [Related]  

  • 19. A foundation for PT (proficiency test) success.
    O'Brien JA
    MLO Med Lab Obs; 1999 Feb; 31(2):44-8. PubMed ID: 10346358
    [No Abstract]   [Full Text] [Related]  

  • 20. Saving laboratory records: what, how, how long?
    Baer D
    MLO Med Lab Obs; 2004 May; 36(5):10-1, 14-6; quiz 18-20. PubMed ID: 15179913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.